MarketCapTrends
IBRX
ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare

ImmunityBio, Inc. Cash on Hand 2013–2025

ImmunityBio, Inc. annual/quarterly cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • ImmunityBio, Inc. cash on hand for the quarter ending December 31, 2025 were 88.3M, a 38.41% decrease year-over-year.
  • ImmunityBio, Inc. cash on hand for 2025 were 88.3M, a 38.41% decrease from 2024.
  • ImmunityBio, Inc. cash on hand for 2024 were 143.4M, a 45.97% decrease from 2023.
  • ImmunityBio, Inc. cash on hand for 2023 were 265.5M, a 153.68% increase from 2022.
  • ImmunityBio, Inc. cash on hand for 2022 were 104.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
ImmunityBio, Inc. Annual Cash on Hand (Millions of US $)
2025$88
2024$143
2023$265
2022$105
2021$181
2020$35
2019$76
2018$17
2017$24
2016$8
2015$176
2014$59
ImmunityBio, Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$88
2024-12-31$143
2023-12-31$265
2022-12-31$105
2021-12-31$181
2020-12-31$35
2019-12-31$76
2018-12-31$17
2017-12-31$24
2016-12-31$8
2015-12-31$176
2014-12-31$59

ImmunityBio, Inc. Cash on Hand — FAQ

ImmunityBio, Inc. (IBRX) cash on hand over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see IBRX's cash on hand history?

The chart and table above show ImmunityBio, Inc.'s cash on hand by year and by quarter, including the growth rate.